Onartuzumab (MetMAb): using nonclinical pharmacokinetic and concentration-effect data to support clinical development. (Q30657838)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Onartuzumab (MetMAb): using nonclinical pharmacokinetic and concentration-effect data to support clinical development. |
scientific article |
Statements
Onartuzumab (MetMAb): using nonclinical pharmacokinetic and concentration-effect data to support clinical development (English)
Hong Xiang
Brendan C Bender
Arthur E Reyes
Nelson L 'shasha' Jumbe
Mally Romero
Teresa Davancaze
Ihsan Nijem
Elaine Mai
Judy Young
Amy Peterson
Lisa A Damico-Beyer